|
Fusion gene ID: 41397 |
FusionGeneSummary for VCL_FGFR2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: VCL_FGFR2 | Fusion gene ID: 41397 | Hgene | Tgene | Gene symbol | VCL | FGFR2 | Gene ID | 7414 | 2263 |
Gene name | vinculin | fibroblast growth factor receptor 2 | |
Synonyms | CMD1W|CMH15|HEL114|MV|MVCL | BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25 | |
Cytomap | 10q22.2 | 10q26.13 | |
Type of gene | protein-coding | protein-coding | |
Description | vinculinepididymis luminal protein 114meta-vinculinmetavinculin | fibroblast growth factor receptor 2BEK fibroblast growth factor receptorbacteria-expressed kinasekeratinocyte growth factor receptorprotein tyrosine kinase, receptor like 14 | |
Modification date | 20180522 | 20180527 | |
UniProtAcc | P18206 | P21802 | |
Ensembl transtripts involved in fusion gene | ENST00000211998, ENST00000372755, ENST00000478896, ENST00000417648, | ENST00000369061, ENST00000357555, ENST00000358487, ENST00000356226, ENST00000369060, ENST00000369059, ENST00000346997, ENST00000457416, ENST00000351936, ENST00000360144, ENST00000369056, ENST00000490349, ENST00000359354, ENST00000478859, | |
Fusion gene scores | * DoF score | 10 X 7 X 10=700 | 7 X 6 X 7=294 |
# samples | 12 | 11 | |
** MAII score | log2(12/700*10)=-2.54432051622381 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(11/294*10)=-1.4183126313117 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: VCL [Title/Abstract] AND FGFR2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation | Oncogene involved fusion gene, in-frame and retained their domain. Kinase involved fusion gene, inframe and retained kinase domain. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | FGFR2 | GO:0008284 | positive regulation of cell proliferation | 8663044 |
Tgene | FGFR2 | GO:0008543 | fibroblast growth factor receptor signaling pathway | 8663044|15629145 |
Tgene | FGFR2 | GO:0018108 | peptidyl-tyrosine phosphorylation | 15629145|16844695 |
Tgene | FGFR2 | GO:0046777 | protein autophosphorylation | 15629145 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | THCA | TCGA-EM-A3FP-01A | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000211998 | ENST00000369061 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000211998 | ENST00000357555 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000211998 | ENST00000358487 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000211998 | ENST00000356226 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000211998 | ENST00000369060 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000211998 | ENST00000369059 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000211998 | ENST00000346997 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000211998 | ENST00000457416 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000211998 | ENST00000351936 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000211998 | ENST00000360144 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000211998 | ENST00000369056 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000211998 | ENST00000490349 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000211998 | ENST00000359354 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000211998 | ENST00000478859 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
In-frame | ENST00000372755 | ENST00000369061 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000372755 | ENST00000357555 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000372755 | ENST00000358487 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000372755 | ENST00000356226 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000372755 | ENST00000369060 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000372755 | ENST00000369059 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000372755 | ENST00000346997 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000372755 | ENST00000457416 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000372755 | ENST00000351936 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000372755 | ENST00000360144 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000372755 | ENST00000369056 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000372755 | ENST00000490349 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000372755 | ENST00000359354 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000372755 | ENST00000478859 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
3UTR-3CDS | ENST00000478896 | ENST00000369061 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
3UTR-intron | ENST00000478896 | ENST00000357555 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
3UTR-intron | ENST00000478896 | ENST00000358487 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
3UTR-intron | ENST00000478896 | ENST00000356226 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
3UTR-intron | ENST00000478896 | ENST00000369060 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
3UTR-intron | ENST00000478896 | ENST00000369059 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
3UTR-intron | ENST00000478896 | ENST00000346997 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
3UTR-intron | ENST00000478896 | ENST00000457416 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
3UTR-intron | ENST00000478896 | ENST00000351936 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
3UTR-intron | ENST00000478896 | ENST00000360144 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
3UTR-intron | ENST00000478896 | ENST00000369056 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
3UTR-intron | ENST00000478896 | ENST00000490349 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
3UTR-intron | ENST00000478896 | ENST00000359354 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
3UTR-intron | ENST00000478896 | ENST00000478859 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
In-frame | ENST00000417648 | ENST00000369061 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000417648 | ENST00000357555 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000417648 | ENST00000358487 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000417648 | ENST00000356226 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000417648 | ENST00000369060 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000417648 | ENST00000369059 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000417648 | ENST00000346997 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000417648 | ENST00000457416 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000417648 | ENST00000351936 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000417648 | ENST00000360144 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000417648 | ENST00000369056 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000417648 | ENST00000490349 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000417648 | ENST00000359354 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
5CDS-intron | ENST00000417648 | ENST00000478859 | VCL | chr10 | 75758133 | + | FGFR2 | chr10 | 123239535 | - |
Top |
FusionProtFeatures for VCL_FGFR2 |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
VCL | FGFR2 |
Actin filament (F-actin)-binding protein involved incell-matrix adhesion and cell-cell adhesion. Regulates cell-surface E-cadherin expression and potentiates mechanosensing bythe E-cadherin complex. May also play important roles in cellmorphology and locomotion. {ECO:0000269|PubMed:20484056}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000351936 | - | 0 | 18 | 154_247 | -216 | 786 | Domain | Note=Ig-like C2-type 2 |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000351936 | - | 0 | 18 | 256_358 | -216 | 786 | Domain | Note=Ig-like C2-type 3 |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000351936 | - | 0 | 18 | 25_125 | -216 | 786 | Domain | Note=Ig-like C2-type 1 |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000351936 | - | 0 | 18 | 481_770 | -216 | 786 | Domain | Protein kinase |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000357555 | - | 0 | 17 | 154_247 | -107 | 708 | Domain | Note=Ig-like C2-type 2 |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000357555 | - | 0 | 17 | 256_358 | -107 | 708 | Domain | Note=Ig-like C2-type 3 |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000357555 | - | 0 | 17 | 25_125 | -107 | 708 | Domain | Note=Ig-like C2-type 1 |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000357555 | - | 0 | 17 | 481_770 | -107 | 708 | Domain | Protein kinase |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000359354 | - | 0 | 7 | 154_247 | -163 | 255 | Domain | Note=Ig-like C2-type 2 |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000359354 | - | 0 | 7 | 256_358 | -163 | 255 | Domain | Note=Ig-like C2-type 3 |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000359354 | - | 0 | 7 | 25_125 | -163 | 255 | Domain | Note=Ig-like C2-type 1 |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000359354 | - | 0 | 7 | 481_770 | -163 | 255 | Domain | Protein kinase |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000360144 | - | 0 | 17 | 154_247 | -207 | 681 | Domain | Note=Ig-like C2-type 2 |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000360144 | - | 0 | 17 | 256_358 | -207 | 681 | Domain | Note=Ig-like C2-type 3 |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000360144 | - | 0 | 17 | 25_125 | -207 | 681 | Domain | Note=Ig-like C2-type 1 |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000360144 | - | 0 | 17 | 481_770 | -207 | 681 | Domain | Protein kinase |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369056 | - | 0 | 17 | 154_247 | -8 | 770 | Domain | Note=Ig-like C2-type 2 |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369056 | - | 0 | 17 | 256_358 | -8 | 770 | Domain | Note=Ig-like C2-type 3 |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369056 | - | 0 | 17 | 25_125 | -8 | 770 | Domain | Note=Ig-like C2-type 1 |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369056 | - | 0 | 17 | 481_770 | -8 | 770 | Domain | Protein kinase |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000351936 | - | 0 | 18 | 487_495 | -216 | 786 | Nucleotide binding | ATP |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000351936 | - | 0 | 18 | 565_567 | -216 | 786 | Nucleotide binding | ATP |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000357555 | - | 0 | 17 | 487_495 | -107 | 708 | Nucleotide binding | ATP |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000357555 | - | 0 | 17 | 565_567 | -107 | 708 | Nucleotide binding | ATP |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000359354 | - | 0 | 7 | 487_495 | -163 | 255 | Nucleotide binding | ATP |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000359354 | - | 0 | 7 | 565_567 | -163 | 255 | Nucleotide binding | ATP |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000360144 | - | 0 | 17 | 487_495 | -207 | 681 | Nucleotide binding | ATP |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000360144 | - | 0 | 17 | 565_567 | -207 | 681 | Nucleotide binding | ATP |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369056 | - | 0 | 17 | 487_495 | -8 | 770 | Nucleotide binding | ATP |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369056 | - | 0 | 17 | 565_567 | -8 | 770 | Nucleotide binding | ATP |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000351936 | - | 0 | 18 | 161_178 | -216 | 786 | Region | Note=Heparin-binding |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000357555 | - | 0 | 17 | 161_178 | -107 | 708 | Region | Note=Heparin-binding |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000359354 | - | 0 | 7 | 161_178 | -163 | 255 | Region | Note=Heparin-binding |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000360144 | - | 0 | 17 | 161_178 | -207 | 681 | Region | Note=Heparin-binding |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369056 | - | 0 | 17 | 161_178 | -8 | 770 | Region | Note=Heparin-binding |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000351936 | - | 0 | 18 | 22_377 | -216 | 786 | Topological domain | Extracellular |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000351936 | - | 0 | 18 | 399_821 | -216 | 786 | Topological domain | Cytoplasmic |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000357555 | - | 0 | 17 | 22_377 | -107 | 708 | Topological domain | Extracellular |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000357555 | - | 0 | 17 | 399_821 | -107 | 708 | Topological domain | Cytoplasmic |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000359354 | - | 0 | 7 | 22_377 | -163 | 255 | Topological domain | Extracellular |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000359354 | - | 0 | 7 | 399_821 | -163 | 255 | Topological domain | Cytoplasmic |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000360144 | - | 0 | 17 | 22_377 | -207 | 681 | Topological domain | Extracellular |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000360144 | - | 0 | 17 | 399_821 | -207 | 681 | Topological domain | Cytoplasmic |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369056 | - | 0 | 17 | 22_377 | -8 | 770 | Topological domain | Extracellular |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369056 | - | 0 | 17 | 399_821 | -8 | 770 | Topological domain | Cytoplasmic |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000351936 | - | 0 | 18 | 378_398 | -216 | 786 | Transmembrane | Helical |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000357555 | - | 0 | 17 | 378_398 | -107 | 708 | Transmembrane | Helical |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000359354 | - | 0 | 7 | 378_398 | -163 | 255 | Transmembrane | Helical |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000360144 | - | 0 | 17 | 378_398 | -207 | 681 | Transmembrane | Helical |
Tgene | >FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369056 | - | 0 | 17 | 378_398 | -8 | 770 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >VCL | chr10:75758133 | chr10:123239535 | ENST00000211998 | + | 1 | 22 | 837_878 | 56 | 1135 | Compositional bias | Pro-rich |
Hgene | >VCL | chr10:75758133 | chr10:123239535 | ENST00000372755 | + | 1 | 21 | 837_878 | 56 | 1067 | Compositional bias | Pro-rich |
Hgene | >VCL | chr10:75758133 | chr10:123239535 | ENST00000211998 | + | 1 | 22 | 1003_1046 | 56 | 1135 | Region | Facilitates phospholipid membrane insertion |
Hgene | >VCL | chr10:75758133 | chr10:123239535 | ENST00000211998 | + | 1 | 22 | 1120_1134 | 56 | 1135 | Region | Facilitates phospholipid membrane insertion |
Hgene | >VCL | chr10:75758133 | chr10:123239535 | ENST00000211998 | + | 1 | 22 | 1_835 | 56 | 1135 | Region | N-terminal globular head |
Hgene | >VCL | chr10:75758133 | chr10:123239535 | ENST00000211998 | + | 1 | 22 | 259_589 | 56 | 1135 | Region | 3 X 112 AA tandem repeats |
Hgene | >VCL | chr10:75758133 | chr10:123239535 | ENST00000211998 | + | 1 | 22 | 836_878 | 56 | 1135 | Region | Linker (Pro-rich) |
Hgene | >VCL | chr10:75758133 | chr10:123239535 | ENST00000211998 | + | 1 | 22 | 879_1134 | 56 | 1135 | Region | C-terminal tail |
Hgene | >VCL | chr10:75758133 | chr10:123239535 | ENST00000372755 | + | 1 | 21 | 1003_1046 | 56 | 1067 | Region | Facilitates phospholipid membrane insertion |
Hgene | >VCL | chr10:75758133 | chr10:123239535 | ENST00000372755 | + | 1 | 21 | 1120_1134 | 56 | 1067 | Region | Facilitates phospholipid membrane insertion |
Hgene | >VCL | chr10:75758133 | chr10:123239535 | ENST00000372755 | + | 1 | 21 | 1_835 | 56 | 1067 | Region | N-terminal globular head |
Hgene | >VCL | chr10:75758133 | chr10:123239535 | ENST00000372755 | + | 1 | 21 | 259_589 | 56 | 1067 | Region | 3 X 112 AA tandem repeats |
Hgene | >VCL | chr10:75758133 | chr10:123239535 | ENST00000372755 | + | 1 | 21 | 836_878 | 56 | 1067 | Region | Linker (Pro-rich) |
Hgene | >VCL | chr10:75758133 | chr10:123239535 | ENST00000372755 | + | 1 | 21 | 879_1134 | 56 | 1067 | Region | C-terminal tail |
Hgene | >VCL | chr10:75758133 | chr10:123239535 | ENST00000211998 | + | 1 | 22 | 259_369 | 56 | 1135 | Repeat | 1 |
Hgene | >VCL | chr10:75758133 | chr10:123239535 | ENST00000211998 | + | 1 | 22 | 370_479 | 56 | 1135 | Repeat | 2 |
Hgene | >VCL | chr10:75758133 | chr10:123239535 | ENST00000211998 | + | 1 | 22 | 480_589 | 56 | 1135 | Repeat | 3 |
Hgene | >VCL | chr10:75758133 | chr10:123239535 | ENST00000372755 | + | 1 | 21 | 259_369 | 56 | 1067 | Repeat | 1 |
Hgene | >VCL | chr10:75758133 | chr10:123239535 | ENST00000372755 | + | 1 | 21 | 370_479 | 56 | 1067 | Repeat | 2 |
Hgene | >VCL | chr10:75758133 | chr10:123239535 | ENST00000372755 | + | 1 | 21 | 480_589 | 56 | 1067 | Repeat | 3 |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000346997 | - | 15 | 17 | 154_247 | 765 | 820 | Domain | Note=Ig-like C2-type 2 |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000346997 | - | 15 | 17 | 256_358 | 765 | 820 | Domain | Note=Ig-like C2-type 3 |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000346997 | - | 15 | 17 | 25_125 | 765 | 820 | Domain | Note=Ig-like C2-type 1 |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000346997 | - | 15 | 17 | 481_770 | 765 | 820 | Domain | Protein kinase |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000356226 | - | 14 | 16 | 154_247 | 650 | 705 | Domain | Note=Ig-like C2-type 2 |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000356226 | - | 14 | 16 | 256_358 | 650 | 705 | Domain | Note=Ig-like C2-type 3 |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000356226 | - | 14 | 16 | 25_125 | 650 | 705 | Domain | Note=Ig-like C2-type 1 |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000356226 | - | 14 | 16 | 481_770 | 650 | 705 | Domain | Protein kinase |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000358487 | - | 16 | 18 | 154_247 | 767 | 822 | Domain | Note=Ig-like C2-type 2 |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000358487 | - | 16 | 18 | 256_358 | 767 | 822 | Domain | Note=Ig-like C2-type 3 |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000358487 | - | 16 | 18 | 25_125 | 767 | 822 | Domain | Note=Ig-like C2-type 1 |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000358487 | - | 16 | 18 | 481_770 | 767 | 822 | Domain | Protein kinase |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369060 | - | 14 | 16 | 154_247 | 651 | 706 | Domain | Note=Ig-like C2-type 2 |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369060 | - | 14 | 16 | 256_358 | 651 | 706 | Domain | Note=Ig-like C2-type 3 |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369060 | - | 14 | 16 | 25_125 | 651 | 706 | Domain | Note=Ig-like C2-type 1 |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369060 | - | 14 | 16 | 481_770 | 651 | 706 | Domain | Protein kinase |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369061 | - | 13 | 15 | 154_247 | 655 | 710 | Domain | Note=Ig-like C2-type 2 |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369061 | - | 13 | 15 | 256_358 | 655 | 710 | Domain | Note=Ig-like C2-type 3 |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369061 | - | 13 | 15 | 25_125 | 655 | 710 | Domain | Note=Ig-like C2-type 1 |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369061 | - | 13 | 15 | 481_770 | 655 | 710 | Domain | Protein kinase |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000457416 | - | 16 | 18 | 154_247 | 768 | 823 | Domain | Note=Ig-like C2-type 2 |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000457416 | - | 16 | 18 | 256_358 | 768 | 823 | Domain | Note=Ig-like C2-type 3 |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000457416 | - | 16 | 18 | 25_125 | 768 | 823 | Domain | Note=Ig-like C2-type 1 |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000457416 | - | 16 | 18 | 481_770 | 768 | 823 | Domain | Protein kinase |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000346997 | - | 15 | 17 | 487_495 | 765 | 820 | Nucleotide binding | ATP |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000346997 | - | 15 | 17 | 565_567 | 765 | 820 | Nucleotide binding | ATP |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000356226 | - | 14 | 16 | 487_495 | 650 | 705 | Nucleotide binding | ATP |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000356226 | - | 14 | 16 | 565_567 | 650 | 705 | Nucleotide binding | ATP |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000358487 | - | 16 | 18 | 487_495 | 767 | 822 | Nucleotide binding | ATP |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000358487 | - | 16 | 18 | 565_567 | 767 | 822 | Nucleotide binding | ATP |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369060 | - | 14 | 16 | 487_495 | 651 | 706 | Nucleotide binding | ATP |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369060 | - | 14 | 16 | 565_567 | 651 | 706 | Nucleotide binding | ATP |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369061 | - | 13 | 15 | 487_495 | 655 | 710 | Nucleotide binding | ATP |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369061 | - | 13 | 15 | 565_567 | 655 | 710 | Nucleotide binding | ATP |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000457416 | - | 16 | 18 | 487_495 | 768 | 823 | Nucleotide binding | ATP |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000457416 | - | 16 | 18 | 565_567 | 768 | 823 | Nucleotide binding | ATP |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000346997 | - | 15 | 17 | 161_178 | 765 | 820 | Region | Note=Heparin-binding |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000356226 | - | 14 | 16 | 161_178 | 650 | 705 | Region | Note=Heparin-binding |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000358487 | - | 16 | 18 | 161_178 | 767 | 822 | Region | Note=Heparin-binding |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369060 | - | 14 | 16 | 161_178 | 651 | 706 | Region | Note=Heparin-binding |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369061 | - | 13 | 15 | 161_178 | 655 | 710 | Region | Note=Heparin-binding |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000457416 | - | 16 | 18 | 161_178 | 768 | 823 | Region | Note=Heparin-binding |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000346997 | - | 15 | 17 | 22_377 | 765 | 820 | Topological domain | Extracellular |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000346997 | - | 15 | 17 | 399_821 | 765 | 820 | Topological domain | Cytoplasmic |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000356226 | - | 14 | 16 | 22_377 | 650 | 705 | Topological domain | Extracellular |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000356226 | - | 14 | 16 | 399_821 | 650 | 705 | Topological domain | Cytoplasmic |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000358487 | - | 16 | 18 | 22_377 | 767 | 822 | Topological domain | Extracellular |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000358487 | - | 16 | 18 | 399_821 | 767 | 822 | Topological domain | Cytoplasmic |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369060 | - | 14 | 16 | 22_377 | 651 | 706 | Topological domain | Extracellular |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369060 | - | 14 | 16 | 399_821 | 651 | 706 | Topological domain | Cytoplasmic |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369061 | - | 13 | 15 | 22_377 | 655 | 710 | Topological domain | Extracellular |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369061 | - | 13 | 15 | 399_821 | 655 | 710 | Topological domain | Cytoplasmic |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000457416 | - | 16 | 18 | 22_377 | 768 | 823 | Topological domain | Extracellular |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000457416 | - | 16 | 18 | 399_821 | 768 | 823 | Topological domain | Cytoplasmic |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000346997 | - | 15 | 17 | 378_398 | 765 | 820 | Transmembrane | Helical |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000356226 | - | 14 | 16 | 378_398 | 650 | 705 | Transmembrane | Helical |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000358487 | - | 16 | 18 | 378_398 | 767 | 822 | Transmembrane | Helical |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369060 | - | 14 | 16 | 378_398 | 651 | 706 | Transmembrane | Helical |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000369061 | - | 13 | 15 | 378_398 | 655 | 710 | Transmembrane | Helical |
Tgene | FGFR2 | chr10:75758133 | chr10:123239535 | ENST00000457416 | - | 16 | 18 | 378_398 | 768 | 823 | Transmembrane | Helical |
Top |
FusionGeneSequence for VCL_FGFR2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_VCL_ENST00000211998_chr10_75758133_+_FGFR2_ENST00000369061_chr10_123239535_-_111aa MPVFHTRTIESILEPVAQQISHLVIMHEEGEVDGKAIPDLTAPVAAVQAAVSNLVREYLDLSQPLEQYSPSYPDTRSSCSSGDDSVFSPD >In-frame_VCL_ENST00000372755_chr10_75758133_+_FGFR2_ENST00000369061_chr10_123239535_-_111aa MPVFHTRTIESILEPVAQQISHLVIMHEEGEVDGKAIPDLTAPVAAVQAAVSNLVREYLDLSQPLEQYSPSYPDTRSSCSSGDDSVFSPD >In-frame_VCL_ENST00000417648_chr10_75758133_+_FGFR2_ENST00000369061_chr10_123239535_-_111aa MPVFHTRTIESILEPVAQQISHLVIMHEEGEVDGKAIPDLTAPVAAVQAAVSNLVREYLDLSQPLEQYSPSYPDTRSSCSSGDDSVFSPD |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_VCL_ENST00000211998_chr10_75758133_+_FGFR2_ENST00000369061_chr10_123239535_-_333nt ATGCCAGTGTTTCATACGCGCACGATCGAGAGCATCCTGGAGCCGGTGGCACAGCAGATCTCCCACCTGGTGATAATGCACGAGGAGGGC GAGGTGGACGGCAAAGCCATTCCTGACCTCACCGCGCCCGTGGCCGCCGTGCAGGCGGCCGTCAGCAACCTCGTCCGGGAATACTTGGAC CTCAGCCAACCTCTCGAACAGTATTCACCTAGTTACCCTGACACAAGAAGTTCTTGTTCTTCAGGAGATGATTCTGTTTTTTCTCCAGAC >In-frame_VCL_ENST00000372755_chr10_75758133_+_FGFR2_ENST00000369061_chr10_123239535_-_333nt ATGCCAGTGTTTCATACGCGCACGATCGAGAGCATCCTGGAGCCGGTGGCACAGCAGATCTCCCACCTGGTGATAATGCACGAGGAGGGC GAGGTGGACGGCAAAGCCATTCCTGACCTCACCGCGCCCGTGGCCGCCGTGCAGGCGGCCGTCAGCAACCTCGTCCGGGAATACTTGGAC CTCAGCCAACCTCTCGAACAGTATTCACCTAGTTACCCTGACACAAGAAGTTCTTGTTCTTCAGGAGATGATTCTGTTTTTTCTCCAGAC >In-frame_VCL_ENST00000417648_chr10_75758133_+_FGFR2_ENST00000369061_chr10_123239535_-_333nt ATGCCAGTGTTTCATACGCGCACGATCGAGAGCATCCTGGAGCCGGTGGCACAGCAGATCTCCCACCTGGTGATAATGCACGAGGAGGGC GAGGTGGACGGCAAAGCCATTCCTGACCTCACCGCGCCCGTGGCCGCCGTGCAGGCGGCCGTCAGCAACCTCGTCCGGGAATACTTGGAC CTCAGCCAACCTCTCGAACAGTATTCACCTAGTTACCCTGACACAAGAAGTTCTTGTTCTTCAGGAGATGATTCTGTTTTTTCTCCAGAC |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_VCL_ENST00000211998_chr10_75758133_+_FGFR2_ENST00000369061_chr10_123239535_-_1950nt GTAGTCGCTGCACAGTCTGTCTCTTCGCCGGTTCCCGGCCCCGTGGATCCTACTTCTCTGTCGCCCGCGGTTCGCCGCCCCGCTCGCCGC CGCGATGCCAGTGTTTCATACGCGCACGATCGAGAGCATCCTGGAGCCGGTGGCACAGCAGATCTCCCACCTGGTGATAATGCACGAGGA GGGCGAGGTGGACGGCAAAGCCATTCCTGACCTCACCGCGCCCGTGGCCGCCGTGCAGGCGGCCGTCAGCAACCTCGTCCGGGAATACTT GGACCTCAGCCAACCTCTCGAACAGTATTCACCTAGTTACCCTGACACAAGAAGTTCTTGTTCTTCAGGAGATGATTCTGTTTTTTCTCC AGACCCCATGCCTTACGAACCATGCCTTCCTCAGTATCCACACATAAACGGCAGTGTTAAAACATGAATGACTGTGTCTGCCTGTCCCCA AACAGGACAGCACTGGGAACCTAGCTACACTGAGCAGGGAGACCATGCCTCCCAGAGCTTGTTGTCTCCACTTGTATATATGGATCAGAG GAGTAAATAATTGGAAAAGTAATCAGCATATGTGTAAAGATTTATACAGTTGAAAACTTGTAATCTTCCCCAGGAGGAGAAGAAGGTTTC TGGAGCAGTGGACTGCCACAAGCCACCATGTAACCCCTCTCACCTGCCGTGCGTACTGGCTGTGGACCAGTAGGACTCAAGGTGGACGTG CGTTCTGCCTTCCTTGTTAATTTTGTAATAATTGGAGAAGATTTATGTCAGCACACACTTACAGAGCACAAATGCAGTATATAGGTGCTG GATGTATGTAAATATATTCAAATTATGTATAAATATATATTATATATTTACAAGGAGTTATTTTTTGTATTGATTTTAAATGGATGTCCC AATGCACCTAGAAAATTGGTCTCTCTTTTTTTAATAGCTATTTGCTAAATGCTGTTCTTACACATAATTTCTTAATTTTCACCGAGCAGA GGTGGAAAAATACTTTTGCTTTCAGGGAAAATGGTATAACGTTAATTTATTAATAAATTGGTAATATACAAAACAATTAATCATTTATAG TTTTTTTTGTAATTTAAGTGGCATTTCTATGCAGGCAGCACAGCAGACTAGTTAATCTATTGCTTGGACTTAACTAGTTATCAGATCCTT TGAAAAGAGAATATTTACAATATATGACTAATTTGGGGAAAATGAAGTTTTGATTTATTTGTGTTTAAATGCTGCTGTCAGACGATTGTT CTTAGACCTCCTAAATGCCCCATATTAAAAGAACTCATTCATAGGAAGGTGTTTCATTTTGGTGTGCAACCCTGTCATTACGTCAACGCA ACGTCTAACTGGACTTCCCAAGATAAATGGTACCAGCGTCCTCTTAAAAGATGCCTTAATCCATTCCTTGAGGACAGACCTTAGTTGAAA TGATAGCAGAATGTGCTTCTCTCTGGCAGCTGGCCTTCTGCTTCTGAGTTGCACATTAATCAGATTAGCCTGTATTCTCTTCAGTGAATT TTGATAATGGCTTCCAGACTCTTTGGCGTTGGAGACGCCTGTTAGGATCTTCAAGTCCCATCATAGAAAATTGAAACACAGAGTTGTTCT GCTGATAGTTTTGGGGATACGTCCATCTTTTTAAGGGATTGCTTTCATCTAATTCTGGCAGGACCTCACCAAAAGATCCAGCCTCATACC TACATCAGACAAAATATCGCCGTTGTTCCTTCTGTACTAAAGTATTGTGTTTTGCTTTGGAAACACCCACTCACTTTGCAATAGCCGTGC AAGATGAATGCAGATTACACTGATCTTATGTGTTACAAAATTGGAGAAAGTATTTAATAAAACCTGTTAATTTTTATACTGACAATAAAA >In-frame_VCL_ENST00000372755_chr10_75758133_+_FGFR2_ENST00000369061_chr10_123239535_-_1950nt GTAGTCGCTGCACAGTCTGTCTCTTCGCCGGTTCCCGGCCCCGTGGATCCTACTTCTCTGTCGCCCGCGGTTCGCCGCCCCGCTCGCCGC CGCGATGCCAGTGTTTCATACGCGCACGATCGAGAGCATCCTGGAGCCGGTGGCACAGCAGATCTCCCACCTGGTGATAATGCACGAGGA GGGCGAGGTGGACGGCAAAGCCATTCCTGACCTCACCGCGCCCGTGGCCGCCGTGCAGGCGGCCGTCAGCAACCTCGTCCGGGAATACTT GGACCTCAGCCAACCTCTCGAACAGTATTCACCTAGTTACCCTGACACAAGAAGTTCTTGTTCTTCAGGAGATGATTCTGTTTTTTCTCC AGACCCCATGCCTTACGAACCATGCCTTCCTCAGTATCCACACATAAACGGCAGTGTTAAAACATGAATGACTGTGTCTGCCTGTCCCCA AACAGGACAGCACTGGGAACCTAGCTACACTGAGCAGGGAGACCATGCCTCCCAGAGCTTGTTGTCTCCACTTGTATATATGGATCAGAG GAGTAAATAATTGGAAAAGTAATCAGCATATGTGTAAAGATTTATACAGTTGAAAACTTGTAATCTTCCCCAGGAGGAGAAGAAGGTTTC TGGAGCAGTGGACTGCCACAAGCCACCATGTAACCCCTCTCACCTGCCGTGCGTACTGGCTGTGGACCAGTAGGACTCAAGGTGGACGTG CGTTCTGCCTTCCTTGTTAATTTTGTAATAATTGGAGAAGATTTATGTCAGCACACACTTACAGAGCACAAATGCAGTATATAGGTGCTG GATGTATGTAAATATATTCAAATTATGTATAAATATATATTATATATTTACAAGGAGTTATTTTTTGTATTGATTTTAAATGGATGTCCC AATGCACCTAGAAAATTGGTCTCTCTTTTTTTAATAGCTATTTGCTAAATGCTGTTCTTACACATAATTTCTTAATTTTCACCGAGCAGA GGTGGAAAAATACTTTTGCTTTCAGGGAAAATGGTATAACGTTAATTTATTAATAAATTGGTAATATACAAAACAATTAATCATTTATAG TTTTTTTTGTAATTTAAGTGGCATTTCTATGCAGGCAGCACAGCAGACTAGTTAATCTATTGCTTGGACTTAACTAGTTATCAGATCCTT TGAAAAGAGAATATTTACAATATATGACTAATTTGGGGAAAATGAAGTTTTGATTTATTTGTGTTTAAATGCTGCTGTCAGACGATTGTT CTTAGACCTCCTAAATGCCCCATATTAAAAGAACTCATTCATAGGAAGGTGTTTCATTTTGGTGTGCAACCCTGTCATTACGTCAACGCA ACGTCTAACTGGACTTCCCAAGATAAATGGTACCAGCGTCCTCTTAAAAGATGCCTTAATCCATTCCTTGAGGACAGACCTTAGTTGAAA TGATAGCAGAATGTGCTTCTCTCTGGCAGCTGGCCTTCTGCTTCTGAGTTGCACATTAATCAGATTAGCCTGTATTCTCTTCAGTGAATT TTGATAATGGCTTCCAGACTCTTTGGCGTTGGAGACGCCTGTTAGGATCTTCAAGTCCCATCATAGAAAATTGAAACACAGAGTTGTTCT GCTGATAGTTTTGGGGATACGTCCATCTTTTTAAGGGATTGCTTTCATCTAATTCTGGCAGGACCTCACCAAAAGATCCAGCCTCATACC TACATCAGACAAAATATCGCCGTTGTTCCTTCTGTACTAAAGTATTGTGTTTTGCTTTGGAAACACCCACTCACTTTGCAATAGCCGTGC AAGATGAATGCAGATTACACTGATCTTATGTGTTACAAAATTGGAGAAAGTATTTAATAAAACCTGTTAATTTTTATACTGACAATAAAA >In-frame_VCL_ENST00000417648_chr10_75758133_+_FGFR2_ENST00000369061_chr10_123239535_-_1948nt AGTCGCTGCACAGTCTGTCTCTTCGCCGGTTCCCGGCCCCGTGGATCCTACTTCTCTGTCGCCCGCGGTTCGCCGCCCCGCTCGCCGCCG CGATGCCAGTGTTTCATACGCGCACGATCGAGAGCATCCTGGAGCCGGTGGCACAGCAGATCTCCCACCTGGTGATAATGCACGAGGAGG GCGAGGTGGACGGCAAAGCCATTCCTGACCTCACCGCGCCCGTGGCCGCCGTGCAGGCGGCCGTCAGCAACCTCGTCCGGGAATACTTGG ACCTCAGCCAACCTCTCGAACAGTATTCACCTAGTTACCCTGACACAAGAAGTTCTTGTTCTTCAGGAGATGATTCTGTTTTTTCTCCAG ACCCCATGCCTTACGAACCATGCCTTCCTCAGTATCCACACATAAACGGCAGTGTTAAAACATGAATGACTGTGTCTGCCTGTCCCCAAA CAGGACAGCACTGGGAACCTAGCTACACTGAGCAGGGAGACCATGCCTCCCAGAGCTTGTTGTCTCCACTTGTATATATGGATCAGAGGA GTAAATAATTGGAAAAGTAATCAGCATATGTGTAAAGATTTATACAGTTGAAAACTTGTAATCTTCCCCAGGAGGAGAAGAAGGTTTCTG GAGCAGTGGACTGCCACAAGCCACCATGTAACCCCTCTCACCTGCCGTGCGTACTGGCTGTGGACCAGTAGGACTCAAGGTGGACGTGCG TTCTGCCTTCCTTGTTAATTTTGTAATAATTGGAGAAGATTTATGTCAGCACACACTTACAGAGCACAAATGCAGTATATAGGTGCTGGA TGTATGTAAATATATTCAAATTATGTATAAATATATATTATATATTTACAAGGAGTTATTTTTTGTATTGATTTTAAATGGATGTCCCAA TGCACCTAGAAAATTGGTCTCTCTTTTTTTAATAGCTATTTGCTAAATGCTGTTCTTACACATAATTTCTTAATTTTCACCGAGCAGAGG TGGAAAAATACTTTTGCTTTCAGGGAAAATGGTATAACGTTAATTTATTAATAAATTGGTAATATACAAAACAATTAATCATTTATAGTT TTTTTTGTAATTTAAGTGGCATTTCTATGCAGGCAGCACAGCAGACTAGTTAATCTATTGCTTGGACTTAACTAGTTATCAGATCCTTTG AAAAGAGAATATTTACAATATATGACTAATTTGGGGAAAATGAAGTTTTGATTTATTTGTGTTTAAATGCTGCTGTCAGACGATTGTTCT TAGACCTCCTAAATGCCCCATATTAAAAGAACTCATTCATAGGAAGGTGTTTCATTTTGGTGTGCAACCCTGTCATTACGTCAACGCAAC GTCTAACTGGACTTCCCAAGATAAATGGTACCAGCGTCCTCTTAAAAGATGCCTTAATCCATTCCTTGAGGACAGACCTTAGTTGAAATG ATAGCAGAATGTGCTTCTCTCTGGCAGCTGGCCTTCTGCTTCTGAGTTGCACATTAATCAGATTAGCCTGTATTCTCTTCAGTGAATTTT GATAATGGCTTCCAGACTCTTTGGCGTTGGAGACGCCTGTTAGGATCTTCAAGTCCCATCATAGAAAATTGAAACACAGAGTTGTTCTGC TGATAGTTTTGGGGATACGTCCATCTTTTTAAGGGATTGCTTTCATCTAATTCTGGCAGGACCTCACCAAAAGATCCAGCCTCATACCTA CATCAGACAAAATATCGCCGTTGTTCCTTCTGTACTAAAGTATTGTGTTTTGCTTTGGAAACACCCACTCACTTTGCAATAGCCGTGCAA GATGAATGCAGATTACACTGATCTTATGTGTTACAAAATTGGAGAAAGTATTTAATAAAACCTGTTAATTTTTATACTGACAATAAAAAT |
Top |
FusionGenePPI for VCL_FGFR2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
VCL | ABI2, C19orf57, TRIP6, CDH1, CTNNB1, PSME1, CORO2B, TGFB1I1, NRAP, PXN, GSN, BCAR1, VASP, SORBS1, SORBS2, CTNNA1, CLTC, DAG1, TUBA1A, SIRT7, CDK2, ITGB1, DNAJC5, TXNL1, SCAF4, URM1, ZC3HAV1L, SVIL, SSU72, SDHAF2, UBR1, VAPB, PGM5, USO1, ATP6V1A, UBA3, TPI1, UFC1, VCP, VCAM1, FN1, PRPF40A, ITGA4, ASNS, CTPS1, ECHS1, EIF5, FERMT2, GINS3, GSS, HSPA5, HSPA9, MSN, PDCD10, PDHA1, PDIA4, PPP1R2, PPP5C, RAP1GDS1, SFN, SNRPF, STK24, TUBB3, UBFD1, DCPS, ERP44, G6PD, GNAI3, ISOC1, PFAS, TBCB, XPO1, YWHAE, YWHAG, YWHAQ, YWHAZ, YWHAH, ASB7, VCL, TEKT1, UNK, PICALM, NTRK1, SELE, EWSR1, FBF1, LPXN, ACTG1, CAPZB, MYO1C, RPS27A, SPTAN1, TLN1, MKNK2, SEC16A, CDCA5, MPDZ, AP3M1, LIMA1, PPHLN1, RBM26, GKAP1, ASCC2, TRIM15, PAK4, FOCAD, TTC21B, UBE2N, HSD17B10, TRIM25, BRCA1 | FGFR2 | FGF1, FGFR2, FGF7, FGF10, PIK3R1, ITGA5, STAT3, PGR, STAT5A, STAT5B, NEDD4, FRS2, CBL, LYN, FYN, HGS, APP, PPM1A, TSPAN3, C8orf74, BEX1, BEX2, ERRFI1, GLCE, HOXC6, MTA3, PDLIM2, RASL10B, RHOBTB2, S100A14, TFF1, FGF5, FGF23, FGF8, PLCG1, FGF2, FGF3, FGF6, FGF9, FGF17, PVRL1, BRAF, MAP3K1, PTPN6, PTPN11, PTPN12, PTPRR, FGFR3, FGFR1, SNX24, GAPVD1, SNX22, UBE4A, IP6K1, RPS6KA3, IFFO2, TMEM30B, DNAJC30, XPR1, GOLGA3, KIDINS220, BCL11A, CEP295, CD44, RPS6KA2, LRRIQ1, RPS6KA1, LITAF, MRAP2, SDC2, FCGRT, SIGLECL1, RAET1E, FAM171B, CHERP, U2SURP, SLC9A6, TIMP1, CCDC120, CD83, PKP4, UBXN4, CTDSP1, CTDSPL, DUSP14, MTMR3 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | VCL | chr10:75758133 | chr10:123239535 | ENST00000211998 | + | 1 | 22 | 741_764 | 56 | 1135 | ACTN4 |
Hgene | VCL | chr10:75758133 | chr10:123239535 | ENST00000372755 | + | 1 | 21 | 741_764 | 56 | 1067 | ACTN4 |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for VCL_FGFR2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | FGFR2 | P21802 | DB00039 | Palifermin | Fibroblast growth factor receptor 2 | biotech | approved |
Tgene | FGFR2 | P21802 | DB08896 | Regorafenib | Fibroblast growth factor receptor 2 | small molecule | approved |
Tgene | FGFR2 | P21802 | DB09079 | Nintedanib | Fibroblast growth factor receptor 2 | small molecule | approved |
Tgene | FGFR2 | P21802 | DB01109 | Heparin | Fibroblast growth factor receptor 2 | small molecule | approved|investigational |
Tgene | FGFR2 | P21802 | DB08901 | Ponatinib | Fibroblast growth factor receptor 2 | small molecule | approved|investigational |
Tgene | FGFR2 | P21802 | DB09078 | Lenvatinib | Fibroblast growth factor receptor 2 | small molecule | approved|investigational |
Tgene | FGFR2 | P21802 | DB01041 | Thalidomide | Fibroblast growth factor receptor 2 | small molecule | approved|investigational|withdrawn |
Top |
RelatedDiseases for VCL_FGFR2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | VCL | C1969639 | Cardiomyopathy, Dilated, 1w | 2 | CTD_human;UNIPROT |
Hgene | VCL | C0029456 | Osteoporosis | 1 | CTD_human |
Hgene | VCL | C0948089 | Acute Coronary Syndrome | 1 | CTD_human |
Hgene | VCL | C2750459 | CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 15 | 1 | CTD_human;UNIPROT |
Tgene | FGFR2 | C2931196 | Craniofacial dysostosis type 1 | 21 | ORPHANET;UNIPROT |
Tgene | FGFR2 | C0220658 | Pfeiffer Syndrome | 10 | UNIPROT |
Tgene | FGFR2 | C0001193 | Apert syndrome | 8 | ORPHANET;UNIPROT |
Tgene | FGFR2 | C1510455 | Acrocephalosyndactylia | 4 | CTD_human |
Tgene | FGFR2 | C0010278 | Craniosynostosis | 3 | CTD_human;HPO |
Tgene | FGFR2 | C0036341 | Schizophrenia | 3 | PSYGENET |
Tgene | FGFR2 | C0376634 | Craniofacial Abnormalities | 3 | CTD_human |
Tgene | FGFR2 | C1458155 | Mammary Neoplasms | 3 | CTD_human |
Tgene | FGFR2 | C0011570 | Mental Depression | 2 | PSYGENET |
Tgene | FGFR2 | C0011581 | Depressive disorder | 2 | PSYGENET |
Tgene | FGFR2 | C0038356 | Stomach Neoplasms | 2 | CTD_human |
Tgene | FGFR2 | C1865070 | SCAPHOCEPHALY, MAXILLARY RETRUSION, AND MENTAL RETARDATION | 2 | CTD_human;ORPHANET;UNIPROT |
Tgene | FGFR2 | C0003090 | Ankylosis | 1 | CTD_human |
Tgene | FGFR2 | C0005586 | Bipolar Disorder | 1 | PSYGENET |
Tgene | FGFR2 | C0008924 | Cleft Lip | 1 | CTD_human |
Tgene | FGFR2 | C0008925 | Cleft Palate | 1 | CTD_human;HPO |
Tgene | FGFR2 | C0010273 | Craniofacial Dysostosis | 1 | CTD_human;HPO |
Tgene | FGFR2 | C0014170 | Endometrial Neoplasms | 1 | CTD_human |
Tgene | FGFR2 | C0018553 | Hamartoma Syndrome, Multiple | 1 | CTD_human |
Tgene | FGFR2 | C0023890 | Liver Cirrhosis | 1 | CTD_human |
Tgene | FGFR2 | C0024121 | Lung Neoplasms | 1 | CTD_human |
Tgene | FGFR2 | C0026613 | Motor Skills Disorders | 1 | CTD_human |
Tgene | FGFR2 | C0033975 | Psychotic Disorders | 1 | PSYGENET |
Tgene | FGFR2 | C0037268 | Skin Abnormalities | 1 | CTD_human |
Tgene | FGFR2 | C0037274 | Dermatologic disorders | 1 | CTD_human |
Tgene | FGFR2 | C0040427 | Tooth Abnormalities | 1 | CTD_human |
Tgene | FGFR2 | C0080178 | Spina Bifida | 1 | CTD_human |
Tgene | FGFR2 | C0206698 | Cholangiocarcinoma | 1 | CTD_human |
Tgene | FGFR2 | C0206762 | Limb Deformities, Congenital | 1 | CTD_human |
Tgene | FGFR2 | C0265269 | Lacrimoauriculodentodigital syndrome | 1 | CTD_human;ORPHANET;UNIPROT |
Tgene | FGFR2 | C0349204 | Nonorganic psychosis | 1 | PSYGENET |
Tgene | FGFR2 | C1450010 | Plagiocephaly, Nonsynostotic | 1 | CTD_human;HPO |
Tgene | FGFR2 | C1852406 | Cutis Gyrata Syndrome of Beare And Stevenson | 1 | CTD_human;ORPHANET;UNIPROT |
Tgene | FGFR2 | C2350233 | Antley-Bixler Syndrome Phenotype | 1 | CTD_human |
Tgene | FGFR2 | C3281247 | BENT BONE DYSPLASIA SYNDROME | 1 | ORPHANET;UNIPROT |
Tgene | FGFR2 | C3714756 | Intellectual Disability | 1 | CTD_human;HPO |